Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects

Clinical trial NCT01110031 · COMPLETED

Trial details

NCT number: NCT01110031
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukaemia, Lymphocytic, Chronic

Start date: 2010-05-13
Primary completion: 2012-04-12
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.